Alliance Pharma Plc (APH) Ordinary 1p
- Add to watchlist
- Create an alert
- This stock can be held in a
Share news, reports & tips
-
Revenue, profits rise for Alliance Pharma
30 September 2024 11:01
(Sharecast News) - Alliance Pharma reported a 2.8% increase in revenue on Monday, to £84.8m on a see-through basis, driven by the robust performance of its Kelo-Cote franchise.
-
Alliance Pharma flags solid rise in first-half revenue
29 July 2024 10:30
(Sharecast News) - Alliance Pharma said in a half-year trading update on Monday that its revenue rose to £84.8m, a 2.8% increase year-on-year, and a 5% increase at constant exchange rates.
-
Alliance Pharma COO stepping down, position to be disestablished
23 July 2024 11:06
(Sharecast News) - Healthcare products group Alliance Pharma announced on Tuesday that its chief operating officer Jeyan Heper would leave the company on 31 August.
-
Alliance Pharma posts strong results after audit delay
19 June 2024 08:41
(Sharecast News) - Alliance Pharma reported strong preliminary results for the year ended 31 December on Wednesday, after an audit delay, driven by a robust second half that led to record sales and expanded...
-
Butterfield out, Sedgwick in as Alliance Pharma CEO
8 May 2024 12:50
(Sharecast News) - Alliance Pharma announced a significant leadership transition on Wednesday, with chief executive Peter Butterfield stepping down from his role to pursue other business interests.
-
Alliance Pharma delays preliminary results
22 April 2024 10:03
(Sharecast News) - International healthcare group Alliance Pharma announced the postponement of its preliminary results for the year ended 31 December on Monday.
-
Alliance Pharma to delay release of 2023 results
5 April 2024 07:39
(Sharecast News) - Shares in Alliance Pharma slipped on Friday after the healthcare company said that its full-year results would be delayed.
-
Alliance Pharma names Camillo Pane as chair
5 February 2024 09:07
(Sharecast News) - Consumer healthcare company Alliance Pharma has appointed Camillo Pane to the role of chairman to "lead the company through its next strategic phase", focusing on organic growth...
-
RBC Capital Markets nudges down Alliance Pharma price target
31 January 2024 10:34
(Sharecast News) - RBC Capital Markets nudged its price target on Alliance Pharma down to 60p from 65p on Wednesday as it said it was rebasing its forecasts as trading normalises.
-
Alliance Pharma expects no profit growth in 2024
29 January 2024 10:51
(Sharecast News) - Consumer healthcare group Alliance Pharma has said that 2023 results will be in line with market expectations but said that profits are unlikely to grow this year due to increased...
-
Alliance Pharma confident after some first-half setbacks
26 September 2023 10:16
(Sharecast News) - Consumer healthcare firm Alliance Pharma reported first-half revenue growth for its Kelo-Cote and Nizoral products on Tuesday, meeting the board's expectations.
-
Alliance Pharma reports resilient first-half trading
18 July 2023 10:00
(Sharecast News) - Alliance Pharma reported see-through revenues of £82.4m in a first-half trading update on Tuesday, representing a 1.1% increase year-on-year.
Company announcements Announcements
-
Notification of Major Holdings
10 October 2024 18:11
Alliance Pharma
-
Interim Results
30 September 2024 07:00
Alliance Pharma
-
Notification of Half Year Results
12 September 2024 07:00
Alliance Pharma
-
Result of AGM
29 July 2024 16:10
Alliance Pharma
-
Half Year Trading Update
29 July 2024 07:00
Alliance Pharma
-
Notification of Major Holdings
23 July 2024 18:22
Alliance Pharma
-
Notification of Major Holdings
23 July 2024 18:18
Alliance Pharma
-
Notification of Major Holdings
23 July 2024 18:17
Alliance Pharma
-
Senior Management and Board Update
23 July 2024 07:00
Alliance Pharma
-
Annual Report and Notice of AGM
3 July 2024 12:46
Alliance Pharma
-
Block Listing Six Monthly Return
2 July 2024 11:00
Alliance Pharma
-
Total Voting Rights
1 July 2024 18:06
Alliance Pharma
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2024. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.